C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 5/00 (2006.01) A61K 31/70 (2006.01) A61K 35/28 (2006.01) A61K 45/06 (2006.01) A61K 48/00 (2006.01) C12N 15/11 (2006.01)
Patent
CA 2147663
Therapeutic combinations of an antisense oligonucleotide and another, non-oligonucleotide chemotherapeutic agent are provided which allows for a reduced dosage of the non-oligonucleotide agent, and hence, reduced toxicity to the host. The anti- sense oligonucleotide component has a nucleotide sequence complementary to at least a portion of the mRNA transcript of a tar- get oncogene or proto-oncongene, the amplification or expression of which is associated with the particular neoplastic disease un- der treatment. The combination is particularly useful in treating leukemias, more particularly as a bone marrow purging agent
Calabretta Bruno
Skorski Tomasz
Borden Ladner Gervais Llp
Temple University - Of The Commonwealth System Of Higher Educati
Thomas Jefferson University
LandOfFree
Combination of antineoplastic agent and antisense... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combination of antineoplastic agent and antisense..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination of antineoplastic agent and antisense... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1881900